RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?

Surgery

Volumn 132, Issue 6, 2002, Pages 952-959

  Gimm, Oliver ^a,b,c,d   Niederle, Barbara E ^a,b,c,d   Weber, Theresa ^a,b,c,d   Bockhorn, Maximilian ^a,b,c,d   Ukkat, Jörg ^a,b,c,d   Brauckhoff, Michael ^a,b,c,d   Thanh, Phuong Nguyen ^a,b,c,d   Frilling, Andreja ^a,b,c,d   Klar, Ernst ^a,b,c,d   Niederle, Bruno ^a,b,c,d   Dralle, Henning ^a,b,c,d  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CODON; DISEASE COURSE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; METASTASIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

EID: 0036919493     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.128559     Document Type: Article

References (25)

1. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-60.
2. Lips CJM, Landsvater RM, Hoppener JWM, Geerdink RA, Blijham G, Jansen-Schillhorn van Veen JM, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 1994;331:828-35.
3. Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-47; discussion 247-50.
4. Gimm O, Sutter T, Dralle H. Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. J Cancer Res Clin Oncol 2001;127:156-65.
5. Dralle H, Gimm O, Simon D, Frank-Raue K, Gortz G, Niederle B, et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 1998;22:744-50; discussion 750-51.
6. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, et al. RET mutations in exons 13 and 14 of FMTC patients. Oncogene 1995;10:2415-9.
7. Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M, et al. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 1998;83:770-4.
8. Hofstra RM, Fattoruso O, Quadro L, Wu Y, Libroia A, Verga U, et al. A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab 1997;82:4176-8.
9. Nilsson O, Tisell LE, Jansson S, Ahlman H, Gimm O, Eng C. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation [letter]. JAMA 1999;281:1587-8.
10. Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G, et al. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Cancer Res 1997;57:2870-2.
11. Machens A, Gimm O, Hinze R, Hoppner W, Boehm BO, Dralle H. Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: Oncological features and biochemical properties. J Clin Endocrinol Metab 2001;86: 1104-9.
12. Frohnauer MK, Decker RA. Update on the MEN 2A c804 RET mutation: Is prophylactic thyroidectomy indicated? Surgery 2000;128:1052-7; discussion 1057-8.
13. Gimm O, Neuberg DS, Marsh DJ, Dahia PL, Hoang-Vu C, Raue F, et al. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene 1999;18:1369-73.
14. Gimm O, Dziema H, Brown J, Hoang-Vu C, Hinze R, Dralle H, et al. Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma. Oncogene 2001;20:2161-70.
15. Rodien P, Jeunemaitre X, Dumont C, Beldjord C, Plouin PF. Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas. Horm Res 1997;47:263-8.
16. Niccoli-Sire P, Murat A, Rohmer V, Franc S, Chabrier G, Baldet L, et al. Familial medullary thyroid carcinoma with noncysteine RET mutations: Pheontype-genotype relationship in a large series of patients. J Clin Endocrinol Metab 2001;86:3746-53.
17. Dralle H, Damm I, Scheumann GF, Kotzerke J, Kupsch E, Geerlings H, et al. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 1994;24:112-21.
18. Hinze R, Gimm O, Brauckhoff M, Schneyer U, Dralle H, Holzhausen HJ. "Physiological" and "neoplastic" C-cell hyperplasia of the thyroid: Morphologically and biologically distinct entities? Pathologe 2001;22:259-65.
19. Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Haas OA, Vierhapper H, et al. Sporadic versus familial medullary thyroid microcarcinoma. Am J Surg Pathol 2001;25:1245-51.
20. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Consensus: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-71.
21. Decker RA. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A. Surgery 1993;114:1059-63.
22. Fugazzola L, Cerutti N, Mannavola D, Ghilardi G, Alberti L, Romoli R, et al. Multigenerational familial medullary thyroid cancer (FMTC): Evidence for FMTC phenocopies and association with papillary thyroid cancer. Clin Endocrinol (Oxf) 2002;56:53-63.
23. Brauckhoff M, Gimm O, Hinze R, Ukkat J, Brauckhoff K, Dralle H. Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutations. Thyroid 2002;12:557-561.
24. Scheuba C, Kaserer K, Weinhausl A, Pandev R, Kaider A, Passler C, et al. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 1999;126:1089-95; discussion 1096.
25. Dralle H, Scheumann GF, Proye C, Bacourt F, Frilling A, Limbert F, et al. The value of lymph node dissection in hereditary medullary thyroid carcinoma: A retrospective, European, multicentre study. J Intern Med 1995;238:357-61.